Who will be eligible for CagriSema
Examples of suitable foamable carriers for use in the compositions disclosed herein include, but are not limited to, alginate and derivatives thereof, carboxymethylcellulose and derivatives thereof, collagen, polysaccharides, including, for example, dextran, dextran derivatives, pectin, starch, modified starches such as starches having additional carboxyl and/or carboxamide groups and/or having hydrophilic side-chains, cellulose and derivatives thereof, agar and derivatives thereof, such as agar stabilized with polyacrylamide, polyethylene oxides, glycol methacrylates, gelatin, gums such as xanthum, guar, karaya, gellan, arabic, tragacanth and locust bean gum, or combinations thereof
The options may be chosen on the product page Purity 99.64% / Avg
If youre curious about BPC-157 or other regenerative therapies, the best next step is a personalized clinical evaluation to determine whether your unique biology is a good fit for our treatment protocols
This inherent restriction has significantly limited the availability of effective AD treatments and has triggered investigation into methods or strategies to bypass the BBB